Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

Lower Mortality With Complete Revascularization in Acute MI Patients With MVD

News Conference News AHA 2025

Lower Mortality With Complete Revascularization in Acute MI Patients With MVD

Michael O'Riordan

November 12, 2025

DETECT-AS: Alert System Increases AV Replacement in Eligible Patients

News Conference News ACC 2025

DETECT-AS: Alert System Increases AV Replacement in Eligible Patients

Michael O'Riordan

April 04, 2025

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

News Conference News AHA 2024

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

November 18, 2024

‘Proof-of-Concept’ AI-ECG May Improve STEMI Care: ARISE

News Conference News AHA 2023

‘Proof-of-Concept’ AI-ECG May Improve STEMI Care: ARISE

Yael L. Maxwell

November 17, 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

Surgeons Support Proposed Changes to Left Main CAD Guidelines

News Conference News EACTS 2023

Surgeons Support Proposed Changes to Left Main CAD Guidelines

Michael O'Riordan

October 13, 2023

Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMI

News Conference News AHA 2022

Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMI

November 10, 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

November 09, 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

November 07, 2022

ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD

News Conference News AHA 2022

ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD

November 06, 2022

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

News Conference News AHA 2022

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

November 06, 2022

High-Sensitivity Troponin Testing on the Rise in the US, but Still Limited

News Conference News AHA 2022

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Michael O'Riordan

November 04, 2022

No Mortality Difference Between PCI and CABG for Left Main CAD: Meta-analysis

News Conference News AHA 2021

No Mortality Difference Between PCI and CABG for Left Main CAD: Meta-analysis

Michael O'Riordan

November 15, 2021

News Conference News AHA 2021

AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients

November 13, 2021

Better Success With Next-Generation Robotic PCI: PRECISION GRX

News Conference News SCAI 2021

Better Success With Next-Generation Robotic PCI: PRECISION GRX

April 30, 2021

Elective PCI Appropriateness Not Linked to Outcomes in the VA System

News Conference News AHA 2020

Elective PCI Appropriateness Not Linked to Outcomes in the VA System

November 23, 2020

CTA Doesn’t Add Value in At-Risk Patients Thought to Have ACS

News Conference News AHA 2020

CTA Doesn’t Add Value in At-Risk Patients Thought to Have ACS

November 20, 2020

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

News Conference News AHA 2020

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

Michael O'Riordan

November 14, 2020

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

News Conference News ACC 2020

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

March 30, 2020

Swift Angiography in Cardiac Arrest Without STEMI: No 1-Year Survival Benefit

News Conference News AHA 2019

Swift Angiography in Cardiac Arrest Without STEMI: No 1-Year Survival Benefit

November 21, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.